|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2004-4-12
|
|
pubmed:abstractText |
Seronegative heart transplant recipients who receive an allograft from seropositive donors have a higher risk of developing cytomegalovirus (CMV) disease and cardiac allograft vasculopathy (CAV) and dysfunction. Neither CMV-specific hyperimmune globulin nor ganciclovir as sole CMV prophylaxis is sufficient to prevent CMV disease in high-risk patients. We retrospectively evaluated the efficacy of CMV-hyperimmune globulin with and without ganciclovir in 207 D+/R- heart transplant recipients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
890-7
|
|
pubmed:dateRevised |
2009-10-8
|
|
pubmed:meshHeading |
pubmed-meshheading:15077033-Adolescent,
pubmed-meshheading:15077033-Adult,
pubmed-meshheading:15077033-Aged,
pubmed-meshheading:15077033-Antilymphocyte Serum,
pubmed-meshheading:15077033-Antiviral Agents,
pubmed-meshheading:15077033-Combined Modality Therapy,
pubmed-meshheading:15077033-Cytomegalovirus Infections,
pubmed-meshheading:15077033-Drug Therapy, Combination,
pubmed-meshheading:15077033-Female,
pubmed-meshheading:15077033-Follow-Up Studies,
pubmed-meshheading:15077033-Ganciclovir,
pubmed-meshheading:15077033-Heart Transplantation,
pubmed-meshheading:15077033-Humans,
pubmed-meshheading:15077033-Immunization, Passive,
pubmed-meshheading:15077033-Immunoglobulins,
pubmed-meshheading:15077033-Immunosuppressive Agents,
pubmed-meshheading:15077033-Male,
pubmed-meshheading:15077033-Middle Aged,
pubmed-meshheading:15077033-Retrospective Studies,
pubmed-meshheading:15077033-Survival Analysis,
pubmed-meshheading:15077033-Time Factors
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients.
|
|
pubmed:affiliation |
Department of Cardiac Surgery, University of Innsbruck, Innsbruck Austria. nikolaos.bonaros@uibk.ac.at
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
